Impact of the COVID-19 Pandemic on Cancer Management in Iran: A Review

Globally, the emergence of the COVID-19 pandemic profoundly impacted cancer management. This review discusses the different perspectives on the effect of the pandemic on cancer care in Iran.

The literature search yielded 38 articles on cancer management in Iran during the COVID-19 pandemic. This study evaluated multiple aspects of cancer management, including screening, diagnosis, surgical and pharmacological management, palliative care, psychological aspects, telemedicine, cancer research, and guidelines and recommendations during the pandemic.

Studies indicate that cancer patients are at a heightened risk of severe COVID-19 infections, with a high risk of requiring invasive ventilation, hospitalization in the ICU, and subsequent death. The pandemic significantly affected cancer screenings, in turn leading to a greater number of advanced disease presentations. Furthermore, some surgical and pharmacological treatments were deferred, complicating risk-benefit assessments resulted in complex and challenging decisions regarding patient care. Cancer patients experienced substantial psychological distress, which was exacerbated by delays in treatment and anxiety about contracting COVID-19. The commentary highlights the critical importance of adaptive measures, such as telemedicine and home-based palliative care, to minimize the effects of future health crises on cancer care.

The significant impact of the pandemic on cancer care highlights the critical nature of ensuring that cancer care is a top priority during public health emergencies to achieve equitable access and quality patient care.